Researchers at McGill University have developed an AI tool that can identify rare groups of cells responsible for driving aggressive cancer progression. The tool, called SIDISH, offers a new way to distinguish which cells within a tumour are most strongly linked to poor patient outcomes. Thuis is an important step toward more precise and effective treatments.
A new platform from Sophia Genetics is helping the health system improve genomic testing workflows and the quality of cancer care, the company says.
Read more here.
Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us